Microbial Natural Products and Biosynthesis
Microbial Natural Products and Biosynthesis is a research topic within Pharmacology. Science Explorer counts 39k research works in it since 1950. 22.5% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the exploration of natural products, particularly from microbial sources, as potential sources of new drugs. It covers various aspects such as genome sequencing, biosynthetic gene clusters, secondary metabolites, and their role in drug discovery. The cluster also emphasizes the significance of marine natural products and the potential of endophytic fungi in providing bioactive compounds for pharmaceutical applications.
- Natural Products
- Drug Discovery
- Secondary Metabolites
- Antibiotics
- Microbial Metabolites
- Genome Sequencing
- Endophytic Fungi
- Marine Natural Products
- Nonribosomal Peptides
- Polyketide Biosynthesis
- Research works
- 39k fractional, since 1950
- In the world top 10%
- 8.7k per year above
- Top-10% rate
- 22.5% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +13% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Microbial Natural Products and Biosynthesis research?
By volume, China and the United States publish the most (2k and 631 works in 2022–2025).
By volume, 2022–2025
- 1 China 2k works
- 2 United States 631 works
- 3 India 548 works
- 4 Germany 280 works
- 5 Japan 275 works
- 6 South Korea 159 works
- 7 Egypt 134 works
- 8 United Kingdom 128 works
- 9 France 113 works
- 10 Indonesia 109 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Microbial Natural Products and Biosynthesis research?
By volume in 2022–2025, Chinese Academy of Sciences publishes the most Microbial Natural Products and Biosynthesis research, followed by Chinese Academy of Medical Sciences & Peking Union Medical College and University of Chinese Academy of Sciences.
By volume, 2022–2025
- 1 Chinese Academy of Sciences China 70 works
- 2 Chinese Academy of Medical Sciences & Peking Union Medical College China 47 works
- 3 University of Chinese Academy of Sciences China 40 works
- 4 Shanghai Jiao Tong University China 37 works
- 5 Zhejiang University China 29 works
- 6 Huazhong University of Science and Technology China 28 works
- 7 Shandong University China 27 works
- 8 The University of Tokyo Japan 26 works
- 9 Yunnan University China 25 works
- 10 Ocean University of China China 25 works
Who are the leading researchers in Microbial Natural Products and Biosynthesis?
The most-cited researchers publishing on Microbial Natural Products and Biosynthesis include Barry M. Trost, E. J. Corey and K. N. Houk.
- 1 Barry M. Trost 3.8k citations
- 2 E. J. Corey 3.6k citations
- 3 K. N. Houk 2.8k citations
- 4 Robert H. Grubbs 2.7k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Microbial Natural Products and Biosynthesis research done?
The largest centres of Microbial Natural Products and Biosynthesis research in 2022–2025 are Beijing (China), Guangzhou (China), Shanghai (China) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Braunschweig, Saarbrücken and Jena.
Largest cities, 2022–2025
Where it is the local speciality
- BraunschweigDE · 27.9 works13×
- SaarbrückenDE · 22.9 works12×
- JenaDE · 23.5 works9.7×
- HaikouCN · 45.8 works9.3×
Location quotient: how much more of its research is in Microbial Natural Products and Biosynthesis than the world average.
Where is the best place to study Microbial Natural Products and Biosynthesis?
Among universities, judged by research, Academy of Scientific and Innovative Research, Hainan Normal University and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Academy of Scientific and Innovative Research India | 52.9 | 17.0% | 9.3× | 17 | +629.7% |
| 2 | Hainan Normal University China | 52.2 | 24.5% | 32.3× | 13 | +114.1% |
| 3 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 51.2 | 18.7% | 8.5× | 47 | +23.6% |
| 4 | China Pharmaceutical University China | 51.0 | 27.8% | 17.2× | 21 | -7.4% |
| 5 | Zhejiang Ocean University China | 50.2 | 15.8% | 10.8× | 10 | +470.8% |
| 6 | Yunnan University China | 48.4 | 16.8% | 11.3× | 25 | +24.7% |
| 7 | Jiangnan University China | 48.3 | 35.0% | 6.2× | 22 | +23.9% |
| 8 | University of Chinese Academy of Sciences China | 48.0 | 26.4% | 4.2× | 40 | +93.3% |
| 9 | Leiden University Netherlands | 47.7 | 50.7% | 4.3× | 8 | -4.5% |
| 10 | Shenyang Pharmaceutical University China | 47.6 | 28.4% | 16.6× | 12 | +21.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Microbial Natural Products and Biosynthesis research growing?
Output in 2018–2022 was 13% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Microbial Natural Products and Biosynthesis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.